WOUND MANAGEMENT TECHNOLOGIES, INC. Contracts & Agreements

Employment Agreement, effective September 1, 2024, by and between Sanara MedTech Inc. and Ronald T. Nixon (Filed With SEC on September 23, 2024)

Separation Agreement and General Release, dated as of May 29, 2024, by and between Sanara MedTech Inc. and Zachary B. Fleming (Filed With SEC on August 12, 2024)

Form of Restricted Stock Award Agreement under the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan (Filed With SEC on August 12, 2024)

First Amendment to Consulting Agreement, dated July 13, 2024, by and between Sanara MedTech Inc. and Ann Beal Salamone (Filed With SEC on August 12, 2024)

Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan (Filed With SEC on June 18, 2024)

Employment Agreement, effective April 15, 2024, by and between Sanara MedTech Inc. and Jacob A. Waldrop (Filed With SEC on April 5, 2024)

Asset Purchase Agreement, dated August 1, 2023, by and among Sanara MedTech Inc., Sanara MedTech Applied Technologies, LLC, The Hymed Group Corporation, Applied Nutritionals, LLC... (Filed With SEC on August 2, 2023)

Professional Services Agreement, dated August 1, 2023, by and between Sanara MedTech Inc. and Dr. George D. Petito (Filed With SEC on August 2, 2023)

Loan Agreement, dated August 1, 2023, between Sanara MedTech Applied Technologies, LLC, Sanara MedTech Inc. and Cadence Bank (Filed With SEC on August 2, 2023)

Transaction Advisory Services Agreement, dated March 1, 2023, by and between Sanara MedTech Inc. and The Catalyst Group, Inc (Filed With SEC on March 20, 2023)

Sanara MedTech Inc. Restated 2014 Omnibus Long Term Incentive Plan dated February 10, 2020 effective upon shareholder approval on July 9, 2020 (Filed With SEC on March 20, 2023)

Form of Restricted Stock Award Agreement for Outside Directors under the Sanara MedTech Inc. Restated 2014 Omnibus Long Term Incentive Plan (2022) (Filed With SEC on March 20, 2023)

Form of Restricted Stock Award Agreement for Employees under the Sanara MedTech Inc. Restated 2014 Omnibus Long Term Incentive Plan (2023) (Filed With SEC on March 20, 2023)

Controlled Equity OfferingSM Sales Agreement, dated February 24, 2023, by and between Sanara MedTech Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 24, 2023)

Separation Agreement and General Release and Waiver, dated December 2, 2022, between Sanara MedTech Inc. and Shawn M. Bowman (Filed With SEC on December 6, 2022)

Membership Interest Purchase Agreement, dated July 1, 2022, by and among Sanara MedTech Inc., Scendia Biologics, LLC and Ryan Phillips (Filed With SEC on July 5, 2022)

Amended and Restated Employment Agreement, dated April 28, 2022, by and between Sanara MedTech Inc. and Zachary B. Fleming (Filed With SEC on April 29, 2022)

Employment Agreement, dated April 28, 2022, by and between Sanara MedTech Inc. and Michael D. McNeil (Filed With SEC on April 29, 2022)

Common Stock Warrant, issued by Sanara MedTech Inc. to Furneaux Capital Holdco, LLC (d/b/a BlueIO) on April 4, 2022 (Filed With SEC on April 8, 2022)

Precision Healing Inc. 2020 Stock Option and Grant Plan (Filed With SEC on April 8, 2022)

Agreement and Plan of Merger, dated April 1, 2022, by and among Sanara MedTech Inc., United Wound and Skin Solutions, LLC, Precision Healing Inc., PH Merger Sub I, Inc., PH Merger... (Filed With SEC on April 4, 2022)

Retirement Agreement, dated December 22, 2021, between Sanara MedTech Inc. and J. Michael Carmena (Filed With SEC on December 22, 2021)

Modification Agreement to Loan Agreement, dated January 15, 2021, between the Company, as Borrower, and Cadence Bank, N.A, as Lender (Filed With SEC on August 16, 2021)

Asset Purchase Agreement, dated July 14, 2021, by and between Sanara MedTech Inc., as Purchaser, and Rochal Industries, LLC, as Seller (Filed With SEC on July 19, 2021)

Consulting Agreement, dated July 14, 2021, by and between Sanara MedTech Inc. and Ann Beal Salamone (Filed With SEC on July 19, 2021)

Description of Securities (Filed With SEC on March 30, 2021)

Form of Restricted Stock Award Agreement under the Sanara MedTech Inc. Restated 2014 Omnibus Long-Term Incentive Plan (Filed With SEC on March 30, 2021)

Underwriting Agreement, dated February 12, 2021, by and between Sanara MedTech Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 17, 2021)

Sublicense Agreement, dated August 27, 2018, between Cellerate, LLC, as Sublicensee, and CGI Cellerate RX, LLC, as Sublicensor (Filed With SEC on February 1, 2021)

Second Amendment of Sublicense Agreement, dated January 26, 2021, between Cellerate, LLC, as Sublicensee, and CGI Cellerate RX, LLC, as Sublicensor (Filed With SEC on February 1, 2021)

First Amendment of Sublicense Agreement, dated May 31, 2019, between Cellerate, LLC, as Sublicensee, and CGI Cellerate RX, LLC, as Sublicensor (Filed With SEC on February 1, 2021)

Loan Agreement, dated January 15, 2021, between the Company, as Borrower, and Cadence Bank, N.A, as Lender (Filed With SEC on January 22, 2021)

Amendment No. 1 to Exclusive License Agreement dated July 7, 2019 with Rochal Industries, LLC (Filed With SEC on November 13, 2020)

Product License Agreement effective May 4, 2020 (Filed With SEC on May 12, 2020)

Promissory Note dated April 22, 2020 (Filed With SEC on April 29, 2020)

Employment Agreement dated June 1, 2019 between Sanara MedTech Inc. and Zachary B. Fleming (Filed With SEC on March 26, 2020)

Employment Agreement dated June 1, 2019 between Sanara MedTech Inc. and Shawn M. Bowman (Filed With SEC on March 26, 2020)

Exclusive License Agreement dated October 1, 2019 between Sanara MedTech Inc. and Rochal Industries, LLC (Filed With SEC on November 14, 2019)

Exclusive License Agreement dated July 7, 2019 between Sanara MedTech Inc. and Rochal Industries, LLC (Filed With SEC on August 14, 2019)

Series F Preferred Stock Certificate of Designations (Filed With SEC on March 21, 2019)

Share Exchange Agreement (Filed With SEC on March 21, 2019)

Contribution Agreement dated August 27, 2018 between Wound Care Innovations, LLC and CGI Cellerate RX, LLC (Filed With SEC on November 14, 2018)

Operating Agreement dated August 27, 2018 between Wound Care Innovations, LLC and CGI Cellerate RX, LLC (Filed With SEC on November 14, 2018)

Sublicense Agreement dated August 27, 2018 between CGI Cellerate RX, LLC and Cellerate, LLC (Filed With SEC on November 14, 2018)

Professional Services Agreement dated August 27, 2018 between Wound Management Technologies, Inc., CGI Cellerate RX, LLC and Cellerate, LLC (Filed With SEC on November 14, 2018)

Convertible Promissory Note to CGI Cellerate RX, LLC (Filed With SEC on November 14, 2018)

Cellerate, LLC Statement of Operations for the month ending September 30, 2018 (Filed With SEC on November 14, 2018)

TERMINATION AGREEMENT (Filed With SEC on October 11, 2017)

AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on March 13, 2017)

Letter Agreement dated April 26, 2016 by and between the Company, Evolution Venture Partners, LLC and Middlebury Securities, LLC (Filed With SEC on May 2, 2016)

Warrant to Purchase Shares of Common Stock (Filed With SEC on May 2, 2016)

CONSULTING AGREEMENT (Filed With SEC on April 29, 2016)

Convertible Promissory Note dated June 26, 2015 between Wound Management Technologies, Inc. and Tonaquint, Inc (Filed With SEC on August 17, 2015)

Exchange Agreement dated June 26, 2015 between Wound Management Technologies, Inc. and Tonaquint, Inc (Filed With SEC on August 17, 2015)

Senior Secured Convertible Promissory Note in Favor of The S. Oden Howell Revocable Trust (Filed With SEC on June 18, 2015)

Term Loan Agreement between Wound Management Technologies, Inc. and The James W. Stuckert Revocable Trust and The S. Oden Howell Revocable Trust (Filed With SEC on June 18, 2015)

Senior Secured Convertible Promissory Note in Favor of The James W. Stuckert Revocable Trust (Filed With SEC on June 18, 2015)

First Amendment to Shipping and Consulting Agreement (Filed With SEC on June 5, 2015)

Certificate of Designations, Number, Voting Power, Preferences And Rights of Series E Convertible Preferred Stock (Filed With SEC on June 5, 2014)

Certificate of Designations, Number, Voting Power, Preferences And Rights of Series C Convertible Preferred Stock (Filed With SEC on February 6, 2014)

FUNDING AGREEMENT (Filed With SEC on December 19, 2013)

Amendment to Drawdown Loan Agreement (Filed With SEC on November 14, 2013)

Amendment to Senior Secured Convertible Drawdown Promissory Note (Filed With SEC on November 14, 2013)

Certificate of Designations, Number, Voting Power, Preferences And Rights of Series D Convertible Preferred Stock (Filed With SEC on November 14, 2013)

Amendment to Letter of Intent (Filed With SEC on November 14, 2013)

Security Agreement dated October 15, 2013 (Filed With SEC on October 22, 2013)

Secured Convertible Drawdown Promissory Note dated October 15, 2013 (Filed With SEC on October 22, 2013)

Loan Agreement dated October 15, 2013 (Filed With SEC on October 22, 2013)

Senior Secured Convertible Drawdown Promissory Note (Filed With SEC on October 18, 2013)

SECURITY AGREEMENT (Filed With SEC on October 15, 2013)

WOUND MANAGEMENT TECHNOLOGIES, INC. AND SUBSIDIARIES SENIOR SECURED CONVERTIBLE PROMISSORY NOTE $1,000,000October 10, 2013Ft. Worth, Texas (Filed With SEC on October 15, 2013)

BROOKHAVEN MEDICAL, INC. 11 Paces West Drive, N.W. Atlanta, Georgia 30327 ###-###-#### (Filed With SEC on October 15, 2013)

Amendment B to Manufacturer Exclusive Distributor Agreement, dated October 1, 2013 (Filed With SEC on October 2, 2013)

Amendment A to Manufacturer Exclusive Distributor Agreement, dated August 7, 2013 (Filed With SEC on October 2, 2013)

Warrant for the Purchase of Shares of Common Stock, dated September 26, 2013 (Filed With SEC on September 26, 2013)

Shipping and Consulting Agreement dated September 20, 2013 (Filed With SEC on September 26, 2013)

Manufacturer Exclusive Distributor Agreement dated June 21, 2013 (Filed With SEC on July 8, 2013)

PROMISSORY NOTE (Filed With SEC on March 22, 2013)

SECOND AMENDMENT TO FORBEARANCE AGREEMENT (Filed With SEC on January 9, 2013)

SECURED SUBORDINATED PROMISSORY NOTE (Filed With SEC on July 19, 2012)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF WOUND MANAGEMENT TECHNOLOGIES, INC. Void after __________, 2017 (Filed With SEC on July 19, 2012)

COMMITMENT LETTER July 10, 2012 (Filed With SEC on July 19, 2012)

EXHIBIT 10.2 (Filed With SEC on November 30, 2011)

WOUND MANAGEMENT TECHNOLOGIES, INC. 2010 OMNIBUS LONG TERM INCENTIVE PLAN March 12, 2010 ARTICLE 1 General Purpose of Plan; Definitions (Filed With SEC on August 16, 2010)

CERTIFICATE OF DESIGNATIONS, NUMBER, VOTING POWER, PREFERENCES AND RIGHTS OF SERIES B CONVERTIBLE REDEEMABLE PREFERRED STOCK OF WOUND MANAGEMENT TECHNOLOGIES, INC.... (Filed With SEC on June 25, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 5, 2010)

PURCHASE AGREEMENT (Filed With SEC on February 9, 2010)

VERISCRIP ROYALTY AGREEMENT (Filed With SEC on February 9, 2010)

wound management technologies, inc. PROMISSORY NOTE (Filed With SEC on February 9, 2010)

ASSET PURCHASE AGREEMENT (Filed With SEC on October 2, 2009)

ROYALTY AGREEMENT (Filed With SEC on October 2, 2009)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on September 21, 2009)

MB SOFTWARE CORPORATION CONVERTIBLE NOTE (Filed With SEC on June 10, 2008)

Manufacturing Agreement dated as of November 28, 2007, by and between Wound Care Innovations, L.L.C. and Applied Nutritionals, LLC (Filed With SEC on November 30, 2007)

Exclusive License dated as of November 28, 2007, by and between Wound Care Innovations, L.L.C. and George Petito (Filed With SEC on November 30, 2007)

Exclusive Patent and Trademark License dated as of November 28, 2007, by and between Wound Care Innovations, L.L.C. and Applied Nutritionals, LLC (Filed With SEC on November 30, 2007)

Debt Conversion Agreement and Release (Filed With SEC on August 25, 2004)

Agreement and Plan of Merger (Filed With SEC on August 25, 2004)

Category

Industry

Companies

Contracts

WOUND MANAGEMENT TECHNOLOGIES, INC. Contracts & Agreements